These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36849560)

  • 1. Bystander CD8 + T cells may be involved in the acute phase of diffuse alveolar damage.
    Ohya M; Tateishi A; Matsumoto Y; Satomi H; Kobayashi M
    Virchows Arch; 2023 Mar; 482(3):605-613. PubMed ID: 36849560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway and parenchyma immune cells in influenza A(H1N1)pdm09 viral and non-viral diffuse alveolar damage.
    Buttignol M; Pires-Neto RC; Rossi E Silva RC; Albino MB; Dolhnikoff M; Mauad T
    Respir Res; 2017 Aug; 18(1):147. PubMed ID: 28774302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Features of the cell composition of inflammatory infiltrate in different phases of diffuse alveolar lung damage with COVID-19].
    Rodionov VE; Avdalyan AM; Konovalov DM; Boriskin NV; Tyurin IN; Protsenko DN; Zayratyants OV; Filipenko ML; Oskorbin IP; Koryukov MA
    Arkh Patol; 2022; 84(3):5-13. PubMed ID: 35639838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vasculitis of small muscular arteries, activation of vessel-infiltrating CD8 T cells seems to be antigen-independent.
    Kobayashi M; Ogawa E; Okuyama R; Kanno H
    Virchows Arch; 2018 Feb; 472(2):271-279. PubMed ID: 29128969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway Pathological Alterations Selectively Associated With Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage - Narrative Review.
    Ortiz G; Garay M; Capelozzi V; Cardinal-Fernández P
    Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):31-37. PubMed ID: 29853259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship.
    Cardinal-Fernández P; Lorente JA; Ballén-Barragán A; Matute-Bello G
    Ann Am Thorac Soc; 2017 Jun; 14(6):844-850. PubMed ID: 28570160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and safety of open lung biopsy in patients with acute respiratory distress syndrome (ARDS).
    Ortiz G; Garay M; Mendoza D; Cardinal-Fernández P
    Med Intensiva (Engl Ed); 2019 Apr; 43(3):139-146. PubMed ID: 29501285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage.
    Sarmiento X; Guardiola JJ; Almirall J; Mesalles E; Mate JL; Soler M; Klamburg J
    Respir Med; 2011 Aug; 105(8):1170-5. PubMed ID: 21570273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma levels of Krebs von den Lungen-6 and geographic appearance on high-resolution computed tomography are associated with diffuse alveolar damage in autopsy cases of acute respiratory distress syndrome: a retrospective study.
    Imai R; Yamada D; Tomishima Y; Nakamura T; So C; Ro S; Okafuji K; Kitamura A; Jinta T; Nishimura N
    BMC Pulm Med; 2022 Aug; 22(1):308. PubMed ID: 35953795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy.
    Kao KC; Hu HC; Chang CH; Hung CY; Chiu LC; Li SH; Lin SW; Chuang LP; Wang CW; Li LF; Chen NH; Yang CT; Huang CC; Tsai YH
    Crit Care; 2015 May; 19(1):228. PubMed ID: 25981598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of diffuse alveolar damage in patients with acute respiratory distress syndrome: a retrospective analysis of clinical autopsies.
    Thille AW; Peñuelas O; Lorente JA; Fernández-Segoviano P; Rodriguez JM; Aramburu JA; Panizo J; Esteban A; Frutos-Vivar F
    Crit Care; 2017 Oct; 21(1):254. PubMed ID: 29052522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study.
    Lorente JA; Cardinal-Fernández P; Muñoz D; Frutos-Vivar F; Thille AW; Jaramillo C; Ballén-Barragán A; Rodríguez JM; Peñuelas O; Ortiz G; Blanco J; Pinheiro BV; Nin N; del Carmen Marin M; Esteban A; Thompson TB
    Intensive Care Med; 2015 Nov; 41(11):1921-30. PubMed ID: 26385863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.
    Kritselis M; Yambayev I; Prilutskiy A; Shevtsov A; Vadlamudi C; Zheng H; Elsadwai M; Ma L; Aniskovich E; Kataria Y; Higgins S; Sarita-Reyes C; Zuo T; Zhao Q; Quillen K; Burks EJ
    Hum Pathol; 2021 Oct; 116():49-62. PubMed ID: 34273395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic heterogeneity of acute respiratory distress syndrome revealed by surgical lung biopsy and its clinical implications.
    Park J; Lee YJ; Lee J; Park SS; Cho YJ; Lee SM; Kim YW; Han SK; Yoo CG
    Korean J Intern Med; 2018 May; 33(3):532-540. PubMed ID: 29088909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Presence of Diffuse Alveolar Damage on Open Lung Biopsy Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
    Cardinal-Fernández P; Bajwa EK; Dominguez-Calvo A; Menéndez JM; Papazian L; Thompson BT
    Chest; 2016 May; 149(5):1155-64. PubMed ID: 26896701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.
    Villalba JA; Hilburn CF; Garlin MA; Elliott GA; Li Y; Kunitoki K; Poli S; Alba GA; Madrigal E; Taso M; Price MC; Aviles AJ; Araujo-Medina M; Bonanno L; Boyraz B; Champion SN; Harris CK; Helland TL; Hutchison B; Jobbagy S; Marshall MS; Shepherd DJ; Barth JL; Hung YP; Ly A; Hariri LP; Turbett SE; Pierce VM; Branda JA; Rosenberg ES; Mendez-Pena J; Chebib I; Rosales IA; Smith RN; Miller MA; Rosas IO; Hardin CC; Baden LR; Medoff BD; Colvin RB; Little BP; Stone JR; Mino-Kenudson M; Shih AR
    Am J Respir Crit Care Med; 2022 Oct; 206(7):857-873. PubMed ID: 35671465
    [No Abstract]   [Full Text] [Related]  

  • 17. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.
    Monjazeb AM; Tietze JK; Grossenbacher SK; Hsiao HH; Zamora AE; Mirsoian A; Koehn B; Blazar BR; Weiss JM; Wiltrout RH; Sckisel GD; Murphy WJ
    PLoS One; 2014; 9(8):e102709. PubMed ID: 25119341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the time course of pathological patterns of lung injury in severe COVID-19.
    Mauad T; Duarte-Neto AN; da Silva LFF; de Oliveira EP; de Brito JM; do Nascimento ECT; de Almeida Monteiro RA; Ferreira JC; de Carvalho CRR; do Nascimento Saldiva PH; Dolhnikoff M
    Respir Res; 2021 Jan; 22(1):32. PubMed ID: 33514373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.